Wadsley J, Ainsworth G, Coulson AB, Garcez K, et al. Results of the SEL-I-METRY phase II trial on resensitisation of advanced iodine refractory differentiated thyroid cancer to radioiodine therapy. Thyroid 2023 Aug 11. doi: 10.1089/thy.2022.0707.
PMID: 37565288